ICD10 code of Fibrosing Mediastinitis and ICD9 code

Fibrosing mediastinitis is classified under the ICD-10 code J98.59 (other diseases of mediastinum, not elsewhere classified) and was historically categorized under the ICD-9 code 519.3 (other diseases of mediastinum). These codes are used for administrative and billing purposes to identify this rare, chronic condition characterized by the proliferation of dense fibrous tissue in the mediastinum.

What is the clinical nature of Fibrosing Mediastinitis?

Fibrosing mediastinitis is a rare and serious condition where excessive fibrous tissue grows in the central chest cavity (the mediastinum). This mass of collagen-rich tissue can compress vital structures, including the superior vena cava, pulmonary arteries, pulmonary veins, and the airways. Because fibrosing mediastinitis often develops as a late complication of an inflammatory process—frequently triggered by histoplasmosis in North America—it is considered a fibro-inflammatory disorder rather than a primary tumor. At DiseaseMaps.org, 93 people with fibrosing mediastinitis have joined our community to share their lived experiences, highlighting the isolation often felt by those managing this complex diagnosis.

How is Fibrosing Mediastinitis diagnosed?

Diagnosing fibrosing mediastinitis is challenging because its symptoms often mimic other respiratory or cardiovascular conditions. Physicians typically utilize a combination of clinical suspicion and high-resolution imaging to confirm the presence of the fibrous mass. Key diagnostic tools include:

• Contrast-enhanced CT scans to visualize the extent of the mediastinal fibrosis.


• MRI or MRA to evaluate the patency of the major vessels compressed by the mass.


• PET scans, which are sometimes used to differentiate active inflammation from older, dense scar tissue.


• Biopsy, though this is often avoided due to the high risk of severe bleeding and the difficulty of accessing the dense, vascularized tissue.

What are the primary complications of Fibrosing Mediastinitis?

The severity of fibrosing mediastinitis is largely determined by which structures are being compressed. When the fibrous tissue encroaches on surrounding anatomy, it can lead to:

1. Superior Vena Cava (SVC) Syndrome: Obstruction of blood flow from the upper body to the heart.


2. Pulmonary artery stenosis: Increased pressure in the lungs leading to pulmonary hypertension.


3. Airway obstruction: Narrowing of the trachea or bronchi, causing chronic cough and shortness of breath.


4. Esophageal compression: Leading to difficulty swallowing (dysphagia).

Is Fibrosing Mediastinitis considered a hereditary condition?

Current medical literature does not classify fibrosing mediastinitis as a hereditary or genetic condition. Instead, the pathology is primarily driven by an exaggerated immune response to a prior infection (most commonly Histoplasma capsulatum) or, less frequently, autoimmune processes. Because it is not an inherited disease, family members are not at an increased genetic risk. However, individuals living with fibrosing mediastinitis should work closely with a multidisciplinary team, including pulmonologists, cardiothoracic surgeons, and infectious disease specialists, to manage the long-term sequelae of the fibrosis.

Next steps

• Consult with a specialized pulmonologist or cardiothoracic surgeon experienced in mediastinal disorders.


• Request a referral to a center of excellence that specializes in rare fibrotic diseases.


• Connect with the 93 community members at DiseaseMaps.org to share resources and coping strategies.


• Keep a detailed log of your symptoms and imaging reports to assist your medical team in tracking the progression of the fibrosis.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Fibrosing Mediastinitis Overview.


• Orphanet: Rare disease database entry for Fibrosing Mediastinitis (ORPHA: 64721).


• PubMed/NCBI: "Clinical manifestations and management of fibrosing mediastinitis" (Review Literature).


• DiseaseMaps.org: Patient community data and lived experience repository.